Category: Prescription Drugs
North America Prescription Drugs
-
U.S. Dietary Supplements Market Size, Share & Trends Analysis Report By Type (OTC, Prescribed), By Ingredient, By Form, By Application, By End-user, By Distribution Channel, And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. dietary supplements market size is expected to reach USD 78.94 billion by 2030, registering a CAGR of 5.7% from 2023 to 2030, according to a new report by Grand View ... Read More
-
The U.S. Medical Weight Loss Market
... greater focus on medical weight loss programs using the new obesity drugs. The big story of 2022 has been the soaring demand for new obesity drugs such as Wegovy, Ozempic and Saxenda, with more new ... Read More
-
North America Healthcare Logistics Market 2023-2027
... during the forecast period. Our report on the healthcare logistics market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report ... Read More
-
US Electric Bus Market 2022-2028
... in the country is among the key factors to drive the growth of the electric bus market in the US. The US Federal Transit Administration (FTA) had offered several grants for the purchase of electric ... Read More
-
The U.S. Weight Loss & Diet Control Market
... Covid-19 pandemic and recession. The big story of 2022 has been the soaring demand for new obesity drugs such as Wegovy and Saxenda, with more new drugs coming soon. The market may be entering a ... Read More
-
Contract Research Organizations in the US - Industry Market Research Report
... for Food and Drug Administration (FDA) approval. An explosion in research and development investment, frustratingly high clinical trial costs and an uptick in patent expirations have driven pharmaceutical companies to outsource clinical trial management. These ... Read More
-
Clostridioides Difficile Infection Treatment Market, by Drug Type (Vancomycin, Metronidazole, Fidaxomicin, and Others (late phase drugs, etc.)), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Clostridiodes Difficile, which produces gram-positive bacterium, is an anaerobic toxin that gets ... Read More
-
North America Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment Type (Antimalarial Agents, and Diagnostic Test); Route of Administration (Oral, and Parenteral); End User (Hospitals, Specialty Clinics, and Others)
... The North America malaria treatment market is expected to grow from US$ 765.63 million in 2022 to US$ 996.80 million by 2028. It is estimated to register a CAGR of 4.5% from 2022 to 2028. ... Read More
-
North America Overactive Bladder Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, and Intravesical Instillation) and Disease Type (Idiopathic Overactive Bladder and Neurogenic Bladder)
... North America overactive bladder treatment market is expected to grow from US$ 1,682.29 million in 2022 to US$ 2,059.43 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to ... Read More
-
Anti-Obesity Drug Market, By Mechanism of Action (Peripherally Acting Anti-Obesity Drugs and Centrally Acting Anti-obesity Drugs), By Prescription/Non- prescription (Prescription Drugs and OTC Drugs), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Obesity is commonly defined as having too much body mass. Body mass index (BMI) of 30 or higher is the usual benchmark for ... Read More
-
Atopic Dermatitis Market, By Drug Class (Corticosteroids, Emollients/Moisturizers, IL-4 & PDE4 Inhibitors, Calcineurin Inhibitors Antibiotics, and Other Drug Classes), By Type of Administration (Topical, Oral, and Injectable), By Prescription Type (Over-the-counter (OTC) and Prescription), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Atopic dermatitis (AD), or eczema, is a chronic condition that causes dry, itchy, ... Read More
-
North American URTI Market 2022-2028
... Group >18 to 400 Years, Age Group >40 to 65 Years, and Age Group >65 Years) Forecast, 2022-2028 Market Overview Upper respiratory tract infection (URTI) is a medical illness caused by an acute infection in ... Read More
-
Anticonvulsant Drugs Market, by Drug Class (Barbiturates, Benzodiazepines, Aromatic allylic alcohols, Carboxamides, Triazine, AMPA receptor antagonists, Carbamate, Hydantoin, Fatty Acid Derivative, GABA analogs, Valproylamides, Others (Propionates, Oxazolidinediones, etc.)), by Route of Administration (Enteral, Parenteral), by Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and ... Read More
-
North America Cold Pain Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Application (Runner's Knee, Tendonitis, Sprains/Sports Sprain, Arthritis Pain, Pain and Swelling After Hip or Knee Replacement, Pain or Swelling Under Cast or Splint, Surgery Recovery, Lower Back Pain, and Others), Offering (Over-the-Counter, Prescription Products, Rehabilitation Exercises, Ice Wrap & Cold Packs, Pads, Compression Therapy, Ice Buckets Without Compression, and Others), and End User (Hospitals, Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Individuals, and Others)
... Under Cast or Splint, Surgery Recovery, Lower Back Pain, and Others), Offering (Over-the-Counter, Prescription Products, Rehabilitation Exercises, Ice Wrap & Cold Packs, Pads, Compression Therapy, Ice Buckets Without Compression, and Others), and End User (Hospitals, ... Read More
-
United States Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... United States, Diabetes is the 7th leading cause of death. Diabetes is a persistent disease that happens either when the pancreas has not produced enough insulin or when the body cannot effectively and efficiently uses ... Read More
-
North America Dry Eye Products Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Antibiotic Drops, Hormone Drops, Artificial Tears (OTC Artificial Tears and Prescription Artificial Tears), and Others] and Type (Prescription Drugs and OTC Drugs)
... (Prescription Drugs and OTC Drugs) The North America dry eye products market is expected to grow from US$ 3,084.29 million in 2021 to US$ 4,421.66 million by 2028. It is estimated to grow at a ... Read More
-
Eye Inflammation Treatment Market, by Drug Class (Monoclonal Antibodies, Antibiotics, Corticosteroids, Antivirals, Antifungal, Others (Analgesics, etc.)), by Dosage Form (Eye Drops, Tablets, Capsules, Others (Ophthalmic Ointments, etc.)), by Distribution Channels, (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Eye inflammation, also known as ocular inflammation, is a disorder marked ... Read More
-
Acne Medication Market, by Drug Class (Retinoid (Topical Retinoid and Oral Retinoid), Antibiotics (Topical Antibiotics and Oral Antibiotics), Fixed Dose Combinations (Clindamycin + Benzoyl Peroxide, Clindamycin + Tretinoin, Adapalene + Benzoyl Peroxide, Tretinoin + Benzoyl Peroxide and Others), Salicylic Acid, Azelaic Acid, Benzoyl Peroxide and Others), by Type (Prescription and OTC), by Indication (Inflammatory Acne and Non-Inflammatory Acne), by Formulation (Topical Medication and Oral Medication), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Peroxide and Others), Salicylic Acid, Azelaic Acid, Benzoyl Peroxide and Others), by Type (Prescription and OTC), by Indication (Inflammatory Acne and Non-Inflammatory Acne), by Formulation (Topical Medication and Oral Medication), by Distribution Channel (Hospital Pharmacies, ... Read More
-
U.S. Diabetic Neuropathy Market, by Drug (Tricyclic Antidepressants (Amitriptyline, Nortyptyline, Imipramine, Desipramine), SSRI (Paroxetine, Citalopram), Anticonvulsants (Gabapentin, Pregabalin, Carbamazepine), Opioids (Tramadol, Tapentadol, Oksikodon), SNRIs (Duloxetine), Other Drugs (Capsaicin, Lidocaine, Botilinum Toxin)) by Type (Peripheral Neuropathy, Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Proximal Neuropathy, Autonomic Neuropathy, Focal Neuropathy), by Route of Administration (Oral, Topical, Injection (Intramuscular)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Diabetic neuropathy is ... Read More
-
UNITED STATES INSULIN DRUGS AND DELIVERY DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... than 2.5% over the forecast period. Since the start of the epidemic, the United States has recorded 79 million cases of COVID-19. Over 960,000 people have died in the United States because of COVID-19. The ... Read More
-
United States Healthcare Fraud Detection Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... COVID-19 epidemic illustrates how public health crises affect emergency departments and hospital systems. The pandemic of COVID-19 had a tremendous impact on healthcare delivery. Urgent adjustments in billing codes, telehealth, and prescriptions enabled health care ... Read More
-
North America Pterygium Drug Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation North America Pterygium Drug Market, By Type ... Read More
-
Pharmacies and Drug Stores Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 446110
... of research. Key Findings: Pharmacies and Drug Stores Industry (U.S.) to reach $333,908,294,300 million by 2029. Pharmacies and Drug Stores Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1) ... Read More
-
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 424200
... countless hours of research. Key Findings: Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.) to reach $916,620,445,623 million by 2029. Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry, including Average EBITDA, Operating Ratios and Sales per ... Read More
-
The U.S. Autism Treatment Centers Market
... provided by therapists. There are waiting lists, significant untapped demand, and private equity investors are backing new ventures. Franchises are emerging. The incidence of autism among American children has soared from 1 in 150 in ... Read More
Research Assistance
